Hudson Bay Capital Management
CSCI

Hudson Bay Capital Management’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Hudson Bay Capital Management’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-137
Closed -$119K – 236
2015
Q3 		$119K Buy
+137
New +$199K 0.01% 194
2015
Q2 		– Sell
-29
Closed -$154K – 261
2015
Q1 		$154K Sell
29
-50
-63% -$287K ﹤0.01% 165
2014
Q4 		$476K Buy
+79
New +$664K 0.01% 158

Other funds holding CSCI

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Hudson Bay Capital Management's CSCI Position: Q4 2015 in Review

Hudson Bay Capital Management sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q4 2015, closing a stake of 137 shares — an estimated $119K sold.

Hudson Bay Capital Management first reported a position in CSCI in Q4 2014 and held it in 3 quarters. The position peaked at $476K in Q4 2014. 17 funds tracked by Wall St. Rank hold CSCI as of Q4 2015.

  • Hudson Bay Capital Management reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Hudson Bay Capital Management sold 137 COSCIENS Biopharma Inc. Common Stock shares in Q4 2015, an estimated $119K.
  • Hudson Bay Capital Management first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2014 and held it in 3 quarters.
  • Hudson Bay Capital Management's COSCIENS Biopharma Inc. Common Stock position peaked at $476K in Q4 2014.
  • 17 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q4 2015.

Based on Hudson Bay Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.